[1]
Hewedy, W.A., Anwar, E.I., Sharara, G.M., Hadi, M.A., Darwish, S.A. and Ismail, C.A. 2022. Oncogenic challenge of bromocriptine and L-arginine versus conventional antidiabetics on diethyl nitrosamine-induced liver tumorigenesis in diabetic rats: focus on AMPK activation. International Journal of Basic & Clinical Pharmacology. 12, 1 (Dec. 2022), 1–9. DOI:https://doi.org/10.18203/2319-2003.ijbcp20223348.